alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>           5
<LEGEND>
               This Schedule contains summary financial information extracted
               from the consolidated balance sheet as of December 31, 1998 and
               and 1997 and the consolidated statement of operations for the
               year ended December 31, 1998 and 1997.
</LEGEND>
<MULTIPLIER>                            1000             
       
<S>                                     <C>                  <C>
<PERIOD-TYPE>                                12-MOS               12-MOS
<FISCAL-YEAR-END>                       DEC-31-1998          DEC-31-1997
<PERIOD-START>                          JAN-01-1998          JAN-01-1997
<PERIOD-END>                            DEC-31-1998          DEC-31-1997
<CASH>                                       33,983                   94
<SECURITIES>                                      0                    0
<RECEIVABLES>                                 9,078                  240
<ALLOWANCES>                                    636                   64
<INVENTORY>                                       0                    0
<CURRENT-ASSETS>                             42,962                  285
<PP&E>                                        2,923                  972
<DEPRECIATION>                                  901                  381
<TOTAL-ASSETS>                               62,716                1,039
<CURRENT-LIABILITIES>                        10,736                1,450
<BONDS>                                           0                2,317
<PREFERRED-MANDATORY>                             0                    0
<PREFERRED>                                       0                    2
<COMMON>                                        157                   11
<OTHER-SE>                                   51,789               (2,715)
<TOTAL-LIABILITY-AND-EQUITY>                 62,716                1,039
<SALES>                                      19,744                1,467
<TOTAL-REVENUES>                             19,863                3,148
<CGS>                                         1,593                1,655
<TOTAL-COSTS>                                29,287                6,703
<OTHER-EXPENSES>                                  0                    0
<LOSS-PROVISION>                                  0                    0
<INTEREST-EXPENSE>                              215                  114
<INCOME-PRETAX>                             (24,723)              (5,306)
<INCOME-TAX>                                      0                    0
<INCOME-CONTINUING>                         (24,723)              (5,306)
<DISCONTINUED>                                    0                    0
<EXTRAORDINARY>                                   0                    0
<CHANGES>                                         0                    0
<NET-INCOME>                                (24,723)              (5,306)
<EPS-PRIMARY>                                 (2.62)               (4.88)
<EPS-DILUTED>                                 (2.62)               (4.88)
        


</TABLE>
<PAGE>

EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Northwest Biotherapeutics, Inc. (the
"Company") on Form 10-Q for the period ended September 30, 2005, as filed with
the Securities and Exchange Commission (the Report), I, Alton L. Boynton,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.

Date: November 14, 2005

/s/ Alton L. Boynton
--------------------
Alton L. Boynton
President
#### § 305.12 Motions to quash or modify an investigation subpena.

Any person upon whom an investigation subpena is served may, within seven (7) days after such service or at any time prior to the return date thereof, whichever is earlier, file a motion to quash or modify such subpena with the administrative law judge who issued such subpena, or in the event the administrative law judge is not available, with the chief administrative law judge for action by himself or herself or by the DOT decisionmaker. Such motions shall be made in writing in conformity with Rules 3 and 4 of the Rules of Practice (part 302 of this subchapter); shall state with particularity the grounds therefor and the relief sought; shall be accompanied by the evidence relied upon and all such factual matter shall be verified in accordance with the provisions of Rule 4(b) of the aforesaid Rules of Practice. Written memoranda or briefs may be filed with the motions, stating the points and authorities relied upon. No oral argument will be heard on such motions unless the chief administrative law judge, the administrative law judge or the DOT decisionmaker directs otherwise. A subpena will be quashed or modified if the evidence whose production is required is not reasonably relevant to the matter under investigation, or the demand made does not describe with sufficient particularity the information sought, or the subpena is unlawful or unduly burdensome. The filing of a motion to quash or modify an investigation subpena shall stay the return date of such subpena until such motion is granted or denied. The DOT decisionmaker may at any time review, upon his or her own initiative, the ruling of an administrative law judge or the chief administrative law judge denying a motion to quash a subpena. In such cases, the DOT decisionmaker may order that the return date of a subpena which he or she has elected to review be stayed pending DOT action thereon.

[Doc. No. 82, 50 FR 2421, Jan. 16, 1985, as amended at 65 FR 6457, Feb. 9, 2000]
FOREIGN CORPORATIONS — TAXATON.

[Cuyahoga Circuit Court,

1896.]

Caldwell, Hale and Marvin, JJ.

#### Cuyahoga Co. (Treas.) v. Chas. T. Brush.

Shares of Stock of Foreign Corporations Paying Taxes on Capital Stock are Exempt.

A foreign corporation having its principal place of business, its business and its property within the state and subject to taxation, the shares of stock in such corporation are exempt from taxation.

Error to the Court of Common Pleas of Cuyahoga county.

Per Curiam.

The question involved in this case is whether foreign corporations, which pay taxes on all their property located in this state, are also liable to pay taxes on their stock.

According to the law of the state, corporations are not compelled to pay taxes on their shares of stock, where they pay taxes on their capital stock. The defendant contends that the same rule applies to foreign corporations which pay taxes on their capital stock in this state County *860Solicitor Kaiser maintained that this was not true, while the Supreme Court has never quite decided this question, although it has decided-points all around the issue involved in the case.

The corporationwhich has been the means of bringing úp this interesting question was incorporated under the laws of West Virginia, and the circuit court hold: That although the corporation was incorporated undr the laws of West Virginia, yet having its principal, place of business in this state and its business being within the state and its property within the state and subject to taxation, the shares of stock in that corporation are exempt from taxation. This results in dismissal of the petition, and a decree will be entered by the plaintiff and a like decree may be taken in this court as expressed in the lower court.
EXHIBIT E

Case:17-03283-LTS Doc#:3513-5 Filed:07/13/18 Entered:07/13/18 18:09:17 Desc:

Exhibit E Page 1 of 2
<TABLE> <S> <C>

<PAGE>

<ARTICLE>       9
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                         6,095
<INT-BEARING-DEPOSITS>                         0
<FED-FUNDS-SOLD>                               0
<TRADING-ASSETS>                               0
<INVESTMENTS-HELD-FOR-SALE>                    118,750
<INVESTMENTS-CARRYING>                         1,593
<INVESTMENTS-MARKET>                           1,567
<LOANS>                                        160,204
<ALLOWANCE>                                    1,349
<TOTAL-ASSETS>                                 301,241
<DEPOSITS>                                     208,132
<SHORT-TERM>                                   17,100
<LIABILITIES-OTHER>                            3,770
<LONG-TERM>                                    52,860
<PREFERRED-MANDATORY>                          36
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     19,343
<TOTAL-LIABILITIES-AND-EQUITY>                 301,241
<INTEREST-LOAN>                                12,137
<INTEREST-INVEST>                              8,173
<INTEREST-OTHER>                               6
<INTEREST-TOTAL>                               20,316
<INTEREST-DEPOSIT>                             8,660
<INTEREST-EXPENSE>                             12,021
<INTEREST-INCOME-NET>                          8,296
<LOAN-LOSSES>                                  200
<SECURITIES-GAINS>                             77
<EXPENSE-OTHER>                                7,259
<INCOME-PRETAX>                                2,165
<INCOME-PRE-EXTRAORDINARY>                     2,165
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,305
<EPS-BASIC>                                    .36
<EPS-DILUTED>                                  .36
<YIELD-ACTUAL>                                 7.19
<LOANS-NON>                                    587
<LOANS-PAST>                                   0
<LOANS-TROUBLED>                               282
<LOANS-PROBLEM>                                0
<ALLOWANCE-OPEN>                               1,176
<CHARGE-OFFS>                                  212
<RECOVERIES>                                   185
<ALLOWANCE-CLOSE>                              1,349
<ALLOWANCE-DOMESTIC>                           1,079
<ALLOWANCE-FOREIGN>                            0
<ALLOWANCE-UNALLOCATED>                        270


</TABLE>
EXHIBIT G 

Schedule of Hours Worked and Aggregate Fees for Each Matter Category 

Matter Total Billed Hours Total Fees 

ADV. PROC. 17-189 – ACP Master LTD. 117.70 $99,762.50 

ADV. PROC. 17-213 – ERS v. ALTAIR 102.80 $93,626.00 

ADV. PROC. 17-219, 17-220 – ALTAIR v. ERS 2.60 $998.00 

ADV. PROC. 17-228, 17-229 - UTIER 0.30 $147.00 

ADV. PROC. 17-257 – UCC v. WHYTE 530.10 $523,075.00 

ADV. PROC. 17-151, 17-152 - PEAJE 1.90 $1,417.00 

ADV. PROC. 17-155, 17-156, 17-159 AMBAC; ASSURED 1.60 $784.00 

CASE ADMINISTRATION/MISCELLANEOUS 274.60 $150,343.50 

CHALLENGES TO PROMESA 4.50 $3,863.00 

CLAIMS ISSUES 21.80 $19,991.50 

COMMITTEE GOVERNANCE AND MEETINGS 157.50 $148,045.00 

COMMUNICATIONS WITH RETIREES 56.20 $50,791.50 

COURT HEARINGS 33.60 $32,182.00 

ECONOMIC AND DISASTER RECOVERY ANALYSIS 5.90 $5,640.00 

EMPLOYMENT OF PROFESSIONALS (JENNER) 102.60 $68,703.50 

EMPLOYMENT OF PROFESSIONALS (OTHER 

PROFESSIONALS) 

120.40 $94,491.00 

ERS BOND ISSUES 0.40 $440.00 

FISCAL PLAN/PLAN OF ADJUSTMENT 261.30 $234,478.50 

GO BONDS ISSUES 4.40 $2,851.00 

GO/COFINA ISSUES 0.20 $98.00 

HEALTHCARE/OPEB ANALYSIS 1.50 $1,768.00 

MEDIATION 499.10 $516,874.50 

PENSION ANALYSIS 39.90 $41,637.00 

PREPA 119.80 $114,557.00 

RULE 2004 INVESTIGATION 21.30 $19,438.00 

NON-WORKING TRAVEL TIME 152.50 $155,615.00 

Sub-Total* 2,634.50 $2,381,617.50

Less 15% Fee Discount on all matters except – Non Working travel $333,900.48 

Less 50% Discount on Non-Working Travel $77,807.50 

Total $1,969,909.52 

Case:17-03283-LTS Doc#:3535-7 Filed:07/16/18 Entered:07/16/18 15:35:03 Desc:

Exhibit G Page 1 of 1
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Transportation

###### Office of the Secretary 

The following Agreements were filed with the Department of Transportation under the provisions of 49 U.S.C. 412 and 414. Answers may be filed within 21 days after the filing of the application.

*Docket Number:*                     OST-2000-7289.                

*Date Filed:*                     April 26, 2000.                

*Parties:*                     Members of the International Air Transport Association.                

*Subject:*                     CBPP/5/Reso/003/99 dated September 8, 1999                 

Finally Adopted Resos & Recommended Practices r1-3 

Minutes—CBPP/5/Meet r-1-600a r-2-606 r-3-RP1600d 

Intended effective date: November 17, 1999.

*Docket Number:*                     OST-2000-7313.                

*Date Filed:*                     April 27, 2000.                

*Parties:*                     Members of the International Air Transport Association.                

*Subject:*                     Mail Vote 075 Resolution 002                 

TC1/TC12 USA/US Territories—Austria, Belgium, Chile, Germany, Italy, Netherlands, Scandinavia, Switzerland Standard Revalidating/Adopting/Amending Resolution 

Intended effective date: 1 October 2000.

*Docket Number:*                     OST-2000-7314.                

*Date Filed:*                     April 27, 2000.                

*Parties:*                     Members of the International Air Transport Association.                

*Subject:*                     PTC2 EUR 0307 dated 18 April 2000 TC2 Within Europe Expedited Resolution 002d                 

Intended effective date: 15 May 2000.

Andrea M. Jenkins, 

Federal Register Liaison. 

[FR Doc. 00-11691 Filed 5-9-00; 8:45 am] 

BILLING CODE 4910-62-P
Editorial Note on Part 302
Editorial Note: Nomenclature changes to part 302 appear at 84 FR 15935, Apr. 16, 2019.

§ 302.5 Amendment of documents. ( a ) An application may be amended prior to the filing of answers thereto, or, if no answer is filed, prior to the issuance of an order establishing further procedures, disposing of the application, or setting the case for hearing. Thereafter, applications may be amended only if leave is granted pursuant to the procedures set forth in § 302.11.
( b ) Except as otherwise provided, if properly amended, a document and any statutory deadline shall be made effective as of the date of original filing but the time prescribed for the filing of an answer or any further responsive document directed towards the amended document shall be computed from the date of the filing of the amendment.
EXHIBIT 32.1



CERTIFICATION
PURSUANT TO

18 U.S.C.
SECTION 1350,

AS ADOPTED
PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002



In
connection with the quarterly report of Northwest Biotherapeutics, Inc. (the “Company”) on Form 10-Q for the period
ended June 30, 2012, as filed with the Securities and Exchange Commission (the “Report”), I, Linda M. Powers, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements
                                                       of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report
                                                       fairly presents, in all material respects, the financial condition and
                                                       results of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





|Date: August 14, 2012 |                    
|--------------------- | -------------------
|                      |                    
|By:                   | /s/ Linda M. Powers
|                      | Name:              
|                      | Title:             
|                      |                    
|                      |
§ 1212.602 Requirements for collecting information. In collecting information for systems of records, the following requirements shall be met: ( a ) Information shall be collected to the greatest extent practicable directly from the subject individual when the information may result in adverse determinations about an individual's rights, benefits, and privileges under Federal programs. Exceptions to this policy may be made under certain circumstances, such as one of the following: ( 1 ) There is a need to verify the accuracy of the information supplied by an individual.
( 2 ) The information can only be obtained from a third party.
( 3 ) There is no risk that information collected from third parties, if inaccurate, could result in an adverse determination to the individual concerned.
( 4 ) Provisions are made to verify with the individual information collected from a third party.
( b ) Each individual who is asked to supply information shall be informed of the following: ( 1 ) The authority (whether granted by statute, or by Executive order of the President) for requesting the information;
( 2 ) Whether disclosure is mandatory or voluntary;
( 3 ) The intended official use of the information;
( 4 ) The routine uses which may be made of the information, as published in the system notices;
( 5 ) The effects, if any, on the individual of not providing all or any part of the requested information.
<PAGE>

                                                                    Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Arch Chemicals, Inc. (the "Company")
on Form 10-Q for the period ending June 30, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Louis S. Massimo,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. (S) 1350,
as adopted pursuant to (S) 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.

/s/ Louis S. Massimo



Louis S. Massimo
Chief Financial Officer
August 12, 2003

A signed original of this written statement required by Section 906 has been
provided to Arch Chemicals, Inc. and will be retained by Arch Chemicals, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.
§ 25.393 Loads parallel to hinge line. ( a ) Control surfaces and supporting hinge brackets must be designed for inertia loads acting parallel to the hinge line.
( b ) In the absence of more rational data, the inertia loads may be assumed to be equal to *KW,* where— ( 1 ) *K* = 24 for vertical surfaces;
( 2 ) *K* = 12 for horizontal surfaces; and
( 3 ) *W* = weight of the movable surfaces.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 3304] 

# SUMMARY:

The Office of Citizen Exchanges, Bureau of Educational and Cultural Affairs of the U.S. Department of State announces the addition of Brazil to the Latin American geographic region for which proposals will be accepted. 

                        The Small Grants Competition was announced on April 20, 2000 in the                         **Federal Register**                         (Volume 65, pg. 21061). The deadline for proposals is June 2, 2000.                     

# ADDITIONAL INFORMATION:

                        Interested organizations should contact Laverne Johnson, 202/619-5337; E-Mail                         *ljohnson@usia.gov.*

Dated: April 26, 2000.

Evelyn S. Lieberman, 

Under Secretary for Public Diplomacy and Public Affairs, U.S. Department of State. 

[FR Doc. 00-11023 Filed 5-2-00; 8:45 am] 

BILLING CODE 4710-11-P
FILED

U.S. COURT OF APPEALS

ELEVENTH CIRCUIT

JUNE 15, 2009

THOMAS K. KAHN

CLERK

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

No. 08-16545

Non-Argument Calendar

________________________

D. C. Docket No. 07-00070-CR-J-20-MCR

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

ASHLEY NICOLE REESE,

Defendant-Appellant.

________________________

Appeal from the United States District Court

for the Middle District of Florida

_________________________

(June 15, 2009)

Before BIRCH, HULL and HILL, Circuit Judges.

PER CURIAM:

James H. Burke, Jr., appointed counsel for Ashley Nicole Reese, has filed a
motion to withdraw on appeal, supported by a brief prepared pursuant to Anders v.

California, 386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Our independent

review of the entire record reveals that counsel’s assessment of the relative merit of

the appeal is correct. Because independent examination of the record reveals no

arguable issues of merit, counsel's motion to withdraw is GRANTED, and Reese’s

supervised-release revocation and resulting sentence are AFFIRMED.

2